Association between hs-CRP/HDL-C ratio and three-month unfavorable outcomes in patients with acute ischemic stroke: a

Huang Luwen1, Xu Lei1, Ouyang Qing-Rong1

  • 1Department of Neurology, Suining Central Hospital, Suining, Sichuan Province, 629000, China.

BMC Neurology
|October 29, 2024
PubMed

Insights

The ratio of high-sensitivity C-reactive protein to HDL cholesterol (hs-CRP/HDL-C) is linked to worse outcomes in acute ischemic stroke (AIS) patients. A higher hs-CRP/HDL-C ratio, especially below 42.74, indicates an increased risk of poor functional outcomes within three months.

Area of Science:

  • Cardiovascular Research
  • Neurology
  • Biomarker Discovery

Background:

  • The prognostic value of the high-sensitivity C-reactive protein to high-density lipoprotein cholesterol (hs-CRP/HDL-C) ratio in acute ischemic stroke (AIS) remains unclear.
  • This study investigates the association between the hs-CRP/HDL-C ratio and three-month unfavorable outcomes in AIS patients.

Purpose of the Study:

  • To establish the relationship between the hs-CRP/HDL-C ratio and clinical outcomes in patients following an acute ischemic stroke.
  • To explore potential nonlinear associations and identify critical thresholds for this ratio in predicting stroke outcomes.

Main Methods:

  • A secondary analysis of a prospective cohort study including 1559 AIS patients.
  • Utilized binary logistic regression and generalized additive models (GAM) to assess the association between the hs-CRP/HDL-C ratio and unfavorable outcomes.
  • Employed a recursive method to identify inflection points and develop tailored regression models.

Main Results:

  • A statistically significant positive association was found between the hs-CRP/HDL-C ratio and the likelihood of poor outcomes in AIS patients (OR=1.013).
  • A nonlinear relationship was observed, with an identified inflection point at a hs-CRP/HDL-C ratio of 42.74.
  • Each unit increase in the hs-CRP/HDL-C ratio below this threshold correlated with a 2.4% increased risk of unfavorable outcomes (OR=1.024).

Conclusions:

  • The hs-CRP/HDL-C ratio demonstrates a positive, nonlinear correlation with poor three-month functional outcomes in AIS patients.
  • A hs-CRP/HDL-C ratio below 42.74 is associated with an elevated risk of adverse outcomes.
  • These findings can inform individualized treatment strategies and clinical counseling for AIS patients.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
61
Acute Coronary Syndrome III: Diagnostic studies01:30

Acute Coronary Syndrome III: Diagnostic studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
3
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
91
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
135